Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast PHYSI-DREAM
NCT03212950Completed
- Sponsor
- Faculty of Medicine, University of Ljubljana
- Start
- Jul 2017
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Faculty of Medicine, University of Ljubljana. Primary endpoint: Time within glucose range 3.9 - 10 mmol/l at 28 hours. Started Jul 2017; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03212950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212950.